首页 > 最新文献

AJOG global reports最新文献

英文 中文
Predicting in vitro fertilization success: the role of hyperglycosylated human chorionic gonadotropin to beta-human chorionic gonadotropin ratio in implantation and early pregnancy outcomes at a private in vitro fertilization center in Baghdad 预测体外受精成功:高糖基化人绒毛膜促性腺激素与β -人绒毛膜促性腺激素比值在着床和早期妊娠结局中的作用在巴格达一家私人体外受精中心
Pub Date : 2025-06-06 DOI: 10.1016/j.xagr.2025.100531
Rasha Fadhil Abas MRCOG, CABOG, JMCOG, MSc-ART, DGO, D.MAS, MBChB, Maad Mahdi Shallal FICOG

Background

This study explores the role of human chorionic gonadotropin (hCG) isoforms in predicting implantation success and early pregnancy outcomes in in vitro fertilization (IVF) patients. Despite advances in reproductive medicine, implantation failure, and early pregnancy loss remain significant challenges. Hyperglycosylated hCG (hCG-H) facilitates trophoblast invasion and angiogenesis, while beta-hCG (β-hCG) supports progesterone production, crucial for pregnancy maintenance. This study assesses the predictive value of these biomarkers in IVF success.

Methods

A prospective cohort study was conducted at Al-Binuk Private IVF Center in Baghdad from January to December 2024, including 100 women aged 20 to 44 years with primary or secondary infertility and normal uterine cavities. Women with endocrine disorders or uterine abnormalities were excluded. All transferred embryos were frozen day 4 or day 5 embryos and were implanted into a prepared uterus. Serum hCG levels, including hCG-H and β-hCG, were measured 10 to 11 days after embryo transfer. Data were analyzed using SPSS, and logistic regression was performed to evaluate the predictive value of these biomarkers.

Results

The mean age of participants was 34.3 years, with 54% having a normal BMI. Primary infertility was more common (73%), with an average infertility duration of 5.9 years. Half of the participants underwent their first IVF attempt. Among pregnancies, 73% resulted in a single embryo, 13% in twins, and 14% experienced pregnancy failure. Higher hCG-H and β-hCG levels were significantly associated with implantation success, and an increased hCG-H to β-hCG ratio further enhanced prediction. Logistic regression showed that higher hCG levels improved implantation success, while age negatively affected outcomes.

Conclusion

Serum hCG-H and β-hCG levels measured postembryo transfer serve as strong predictors of IVF success. Their ratio further enhances predictive accuracy, emphasizing their role in assessing pregnancy viability. Further research is needed to refine diagnostic thresholds and enhance fertility treatment strategies.
本研究探讨了人绒毛膜促性腺激素(hCG)异构体在体外受精(IVF)患者中预测植入成功和早期妊娠结局的作用。尽管生殖医学取得了进步,但着床失败和早期妊娠丢失仍然是重大挑战。高糖基化hCG (hCG- h)促进滋养细胞侵袭和血管生成,而β-hCG (β-hCG)支持孕酮的产生,对维持妊娠至关重要。本研究评估了这些生物标志物对体外受精成功的预测价值。方法于2024年1月至12月在巴格达Al-Binuk Private IVF中心进行前瞻性队列研究,纳入100名20 ~ 44岁原发性或继发性不孕、子宫腔正常的女性。排除有内分泌失调或子宫异常的妇女。所有移植的胚胎冷冻第4天或第5天胚胎并植入准备好的子宫。在胚胎移植后10至11天测定血清hCG水平,包括hCG- h和β-hCG。使用SPSS软件对数据进行分析,并进行logistic回归,评估这些生物标志物的预测价值。结果参与者的平均年龄为34.3岁,54%的人BMI正常。原发性不孕症更为常见(73%),平均不孕症持续时间为5.9年。一半的参与者进行了第一次试管婴儿尝试。在怀孕中,73%的人只产生一个胚胎,13%的人产生双胞胎,14%的人怀孕失败。较高的hCG-H和β-hCG水平与植入成功显著相关,hCG-H与β-hCG比值的增加进一步增强了预测。逻辑回归显示,hCG水平越高,植入成功率越高,而年龄对植入结果有负面影响。结论胚胎移植后血清hCG-H和β-hCG水平可作为体外受精成功率的预测指标。它们的比值进一步提高了预测的准确性,强调了它们在评估妊娠生存能力方面的作用。需要进一步的研究来完善诊断阈值和加强生育治疗策略。
{"title":"Predicting in vitro fertilization success: the role of hyperglycosylated human chorionic gonadotropin to beta-human chorionic gonadotropin ratio in implantation and early pregnancy outcomes at a private in vitro fertilization center in Baghdad","authors":"Rasha Fadhil Abas MRCOG, CABOG, JMCOG, MSc-ART, DGO, D.MAS, MBChB,&nbsp;Maad Mahdi Shallal FICOG","doi":"10.1016/j.xagr.2025.100531","DOIUrl":"10.1016/j.xagr.2025.100531","url":null,"abstract":"<div><h3>Background</h3><div>This study explores the role of human chorionic gonadotropin (hCG) isoforms in predicting implantation success and early pregnancy outcomes in in vitro fertilization (IVF) patients. Despite advances in reproductive medicine, implantation failure, and early pregnancy loss remain significant challenges. Hyperglycosylated hCG (hCG-H) facilitates trophoblast invasion and angiogenesis, while beta-hCG (β-hCG) supports progesterone production, crucial for pregnancy maintenance. This study assesses the predictive value of these biomarkers in IVF success.</div></div><div><h3>Methods</h3><div>A prospective cohort study was conducted at Al-Binuk Private IVF Center in Baghdad from January to December 2024, including 100 women aged 20 to 44 years with primary or secondary infertility and normal uterine cavities. Women with endocrine disorders or uterine abnormalities were excluded. All transferred embryos were frozen day 4 or day 5 embryos and were implanted into a prepared uterus. Serum hCG levels, including hCG-H and β-hCG, were measured 10 to 11 days after embryo transfer. Data were analyzed using SPSS, and logistic regression was performed to evaluate the predictive value of these biomarkers.</div></div><div><h3>Results</h3><div>The mean age of participants was 34.3 years, with 54% having a normal BMI. Primary infertility was more common (73%), with an average infertility duration of 5.9 years. Half of the participants underwent their first IVF attempt. Among pregnancies, 73% resulted in a single embryo, 13% in twins, and 14% experienced pregnancy failure. Higher hCG-H and β-hCG levels were significantly associated with implantation success, and an increased hCG-H to β-hCG ratio further enhanced prediction. Logistic regression showed that higher hCG levels improved implantation success, while age negatively affected outcomes.</div></div><div><h3>Conclusion</h3><div>Serum hCG-H and β-hCG levels measured postembryo transfer serve as strong predictors of IVF success. Their ratio further enhances predictive accuracy, emphasizing their role in assessing pregnancy viability. Further research is needed to refine diagnostic thresholds and enhance fertility treatment strategies.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100531"},"PeriodicalIF":0.0,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144517739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TGF-β drives myofibroblast activation and inflammatory mediator production in vulvar lichen sclerosus TGF-β驱动外阴硬化地衣肌成纤维细胞活化和炎症介质产生
Pub Date : 2025-06-05 DOI: 10.1016/j.xagr.2025.100528
Sarah A. Fischer BS , Zahra Mahamed MS , Ashley Updike BS , Briana Boachie BS , Caitriona Greene BS , Ruth Agwaze BS , Kira Parr BS , Tanzy Love PhD , Adrienne D. Bonham MD , Mitchell A. Linder MD , Megan L. Falsetta PhD

Objective

Vulvar lichen sclerosus (VLS) is a chronic inflammatory skin condition characterized by whitening of the external genitalia, debilitating pruritus (itching), and pain. As disease advances, loss of labia, burying of vulvar anatomy (ie, clitoris, urethra, vaginal opening), and vulvar cancer can occur, yet mechanistic understanding of these events remains limited. VLS lesions appear visibly similar to scars and are frequently referred to as such. Therefore, we investigated the role of fibrosis in the VLS disease mechanism with the goal of identifying targets for new therapeutic and diagnostic strategies.

Study design

6-mm biopsies were collected from 8 participants with VLS from regions of the vulva visibly affected by lichen sclerosus (“scarred”) and adjacent unaffected areas (“unscarred”), allowing each patient to serve as their own control thus diminishing biological noise. Specimens were also used to establish fibroblast strains, and cells were stimulated with TGF-β to assess fibroblast-to-myofibroblast transitions, extracellular matrix (ECM) production, and inflammatory responses in scarred versus unscarred areas.

Results

Fibroblasts from scarred areas expressed higher levels of cytoskeletal proteins (alpha-smooth muscle actin) and inflammatory mediators (interleukin 6, prostaglandin E2) upon TGF-β stimulation compared to their unscarred counterparts. Treatment with SB-431542, a TGF-β receptor inhibitor, quelled these responses (P≤.05), indicating that these effects are mediated through the TGF-β pathway. Fibroblasts isolated from scarred tissues exhibit myofibroblast morphologies, but so do fibroblasts from unscarred areas.

Conclusion

TGF-β activates myofibroblasts and exacerbates inflammation in VLS cells from scarred areas. However, fibroblasts from both scarred and unscarred areas show similarities in morphology and ECM production, suggesting molecular changes may occur in VLS skin before visible changes are detected, which could lead to new diagnostic strategies to treat disease before irreversible architectural changes occur.
目的:硬化性地衣(VLS)是一种慢性炎症性皮肤病,其特征是外生殖器变白,虚弱性瘙痒(瘙痒)和疼痛。随着疾病的进展,可能发生阴唇丧失、外阴解剖(即阴蒂、尿道、阴道口)埋藏和外阴癌,但对这些事件的机制了解仍然有限。VLS病变看起来与疤痕明显相似,经常被称为疤痕。因此,我们研究了纤维化在VLS疾病机制中的作用,目的是确定新的治疗和诊断策略的靶点。研究设计从8名VLS患者的外阴明显受硬化地衣影响的区域(“瘢痕”)和邻近未受影响的区域(“未瘢痕”)收集6毫米活检,允许每个患者作为自己的对照,从而减少生物噪音。标本也用于建立成纤维细胞株,并用TGF-β刺激细胞,以评估疤痕区与未疤痕区成纤维细胞向肌成纤维细胞的转变、细胞外基质(ECM)的产生和炎症反应。结果疤痕区成纤维细胞在TGF-β刺激下表达更高水平的细胞骨架蛋白(α -平滑肌肌动蛋白)和炎症介质(白细胞介素6、前列腺素E2)。TGF-β受体抑制剂SB-431542可以抑制这些反应(P≤0.05),表明这些作用是通过TGF-β途径介导的。从瘢痕组织分离的成纤维细胞表现为肌成纤维细胞形态,但从未瘢痕组织分离的成纤维细胞也表现为肌成纤维细胞形态。结论tgf -β可激活瘢痕区VLS细胞的肌成纤维细胞并加重炎症反应。然而,疤痕和未疤痕区域的成纤维细胞在形态和ECM产生方面表现出相似性,这表明在检测到可见变化之前,VLS皮肤可能发生了分子变化,这可能导致在不可逆的结构变化发生之前治疗疾病的新诊断策略。
{"title":"TGF-β drives myofibroblast activation and inflammatory mediator production in vulvar lichen sclerosus","authors":"Sarah A. Fischer BS ,&nbsp;Zahra Mahamed MS ,&nbsp;Ashley Updike BS ,&nbsp;Briana Boachie BS ,&nbsp;Caitriona Greene BS ,&nbsp;Ruth Agwaze BS ,&nbsp;Kira Parr BS ,&nbsp;Tanzy Love PhD ,&nbsp;Adrienne D. Bonham MD ,&nbsp;Mitchell A. Linder MD ,&nbsp;Megan L. Falsetta PhD","doi":"10.1016/j.xagr.2025.100528","DOIUrl":"10.1016/j.xagr.2025.100528","url":null,"abstract":"<div><h3>Objective</h3><div>Vulvar lichen sclerosus (VLS) is a chronic inflammatory skin condition characterized by whitening of the external genitalia, debilitating pruritus (itching), and pain. As disease advances, loss of labia, burying of vulvar anatomy (ie, clitoris, urethra, vaginal opening), and vulvar cancer can occur, yet mechanistic understanding of these events remains limited. VLS lesions appear visibly similar to scars and are frequently referred to as such. Therefore, we investigated the role of fibrosis in the VLS disease mechanism with the goal of identifying targets for new therapeutic and diagnostic strategies.</div></div><div><h3>Study design</h3><div>6-mm biopsies were collected from 8 participants with VLS from regions of the vulva visibly affected by lichen sclerosus (“scarred”) and adjacent unaffected areas (“unscarred”), allowing each patient to serve as their own control thus diminishing biological noise. Specimens were also used to establish fibroblast strains, and cells were stimulated with TGF-β to assess fibroblast-to-myofibroblast transitions, extracellular matrix (ECM) production, and inflammatory responses in scarred versus unscarred areas.</div></div><div><h3>Results</h3><div>Fibroblasts from scarred areas expressed higher levels of cytoskeletal proteins (alpha-smooth muscle actin) and inflammatory mediators (interleukin 6, prostaglandin E2) upon TGF-β stimulation compared to their unscarred counterparts. Treatment with SB-431542, a TGF-β receptor inhibitor, quelled these responses (<em>P</em>≤.05), indicating that these effects are mediated through the TGF-β pathway. Fibroblasts isolated from scarred tissues exhibit myofibroblast morphologies, but so do fibroblasts from unscarred areas.</div></div><div><h3>Conclusion</h3><div>TGF-β activates myofibroblasts and exacerbates inflammation in VLS cells from scarred areas. However, fibroblasts from both scarred and unscarred areas show similarities in morphology and ECM production, suggesting molecular changes may occur in VLS skin before visible changes are detected, which could lead to new diagnostic strategies to treat disease before irreversible architectural changes occur.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100528"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A descriptive analysis of a fertility services waitlist in Eastern Canada 加拿大东部生育服务候补名单的描述性分析
Pub Date : 2025-06-05 DOI: 10.1016/j.xagr.2025.100525
Hannah M. Murphy BSc , Bailey P.S. Cox BSc , Heather M. Manning BSc , Zohreh Zeidy BSc , Sarah Benson MD , John D. Cullen MSc , Deanna Murphy MD , Sean Murphy MD , Sarah Healey MD , Laurie Twells PhD , Katie P. Wadden PhD

Background

Infertility is common and impacts quality of life. Maternal age is an important factor in fertility status, and therefore, timely access to care is critical. Long waits for specialist care remain a reality in Canada, representing an opportunity for early intervention.

Objective

This study aimed to characterize the population seeking infertility care in Newfoundland and Labrador (NL).

Study Design

A province-wide, cross-sectional analysis of referrals to Newfoundland and Labrador Fertility Services (NLFS) was conducted. Deidentified data were extracted from patient records. Descriptive analyses of the reason for referral, provincial geographical health zone, and female age, and a comparison of the age of patients referred across the province were completed. Historical live birth data were used to adjust for population differences.

Results

There were 317 eligible referrals received by NLFS over a 6-month period. The most common reason for referral was infertility (n=221, 70%). The overall mean age of referred females was 33.09 years (SD=5.03). The Eastern-Urban region had the highest number of referrals (n=145, 66%), which was greater than expected based on live birth rates (P≤.001). Patients referred from areas outside of the Eastern-Urban region were younger (P≤.001).

Conclusion

Infertility was the most common reason for referral. The age of females referred for infertility emphasizes the need for prompt intervention. There were differences in referral patterns across the province, including a disproportionately high referral rate in the Eastern-Urban region.
生育能力低下是一种普遍现象,影响着人们的生活质量。产妇年龄是影响生育状况的一个重要因素,因此,及时获得护理至关重要。在加拿大,长时间等待专科护理仍然是一个现实,这代表了早期干预的机会。目的本研究旨在描述纽芬兰和拉布拉多(NL)寻求不孕症治疗的人群。研究设计在全省范围内,对转介到纽芬兰和拉布拉多生育服务(NLFS)的患者进行了横断面分析。从患者记录中提取未识别的数据。对转诊原因、省地理卫生区和女性年龄进行了描述性分析,并对全省转诊患者的年龄进行了比较。历史活产数据用于调整人口差异。结果在6个月的时间里,NLFS共收到317例符合条件的转诊。最常见的转诊原因是不孕症(n=221, 70%)。女性患者总体平均年龄为33.09岁(SD=5.03)。东部城市地区的转诊人数最多(n=145, 66%),高于活产率的预期(P≤0.001)。来自东部城区以外地区的患者更年轻(P≤0.001)。结论不孕症是最常见的转诊原因。因不孕症而转诊的女性年龄强调了及时干预的必要性。全省转诊模式存在差异,包括东部城区的转诊率高得不成比例。
{"title":"A descriptive analysis of a fertility services waitlist in Eastern Canada","authors":"Hannah M. Murphy BSc ,&nbsp;Bailey P.S. Cox BSc ,&nbsp;Heather M. Manning BSc ,&nbsp;Zohreh Zeidy BSc ,&nbsp;Sarah Benson MD ,&nbsp;John D. Cullen MSc ,&nbsp;Deanna Murphy MD ,&nbsp;Sean Murphy MD ,&nbsp;Sarah Healey MD ,&nbsp;Laurie Twells PhD ,&nbsp;Katie P. Wadden PhD","doi":"10.1016/j.xagr.2025.100525","DOIUrl":"10.1016/j.xagr.2025.100525","url":null,"abstract":"<div><h3>Background</h3><div>Infertility is common and impacts quality of life. Maternal age is an important factor in fertility status, and therefore, timely access to care is critical. Long waits for specialist care remain a reality in Canada, representing an opportunity for early intervention.</div></div><div><h3>Objective</h3><div>This study aimed to characterize the population seeking infertility care in Newfoundland and Labrador (NL).</div></div><div><h3>Study Design</h3><div>A province-wide, cross-sectional analysis of referrals to Newfoundland and Labrador Fertility Services (NLFS) was conducted. Deidentified data were extracted from patient records. Descriptive analyses of the reason for referral, provincial geographical health zone, and female age, and a comparison of the age of patients referred across the province were completed. Historical live birth data were used to adjust for population differences.</div></div><div><h3>Results</h3><div>There were 317 eligible referrals received by NLFS over a 6-month period. The most common reason for referral was infertility (n=221, 70%). The overall mean age of referred females was 33.09 years (<em>SD</em>=5.03). The Eastern-Urban region had the highest number of referrals (n=145, 66%), which was greater than expected based on live birth rates (<em>P</em>≤.001). Patients referred from areas outside of the Eastern-Urban region were younger (<em>P</em>≤.001).</div></div><div><h3>Conclusion</h3><div>Infertility was the most common reason for referral. The age of females referred for infertility emphasizes the need for prompt intervention. There were differences in referral patterns across the province, including a disproportionately high referral rate in the Eastern-Urban region.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100525"},"PeriodicalIF":0.0,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden and risk factors of cervical cancer in Vietnam from 1990 to 2021 and forecasting to 2050—a systematic analysis from global burden disease 1990 - 2021年越南宫颈癌负担、危险因素及2050年预测——来自全球负担疾病的系统分析
Pub Date : 2025-06-04 DOI: 10.1016/j.xagr.2025.100526
Bao Huy Le MD , Thao-Ngan Nguyen Pham MD , Huong-Dung Thi Nguyen MD , Tri Cuong Phan MD , Han My Nguyen Le , Thien Tan Tri Tai Truyen MD , Tam Duc Lam MD, PhD

Background

Cervical cancer continues to be a significant global health challenge, with Vietnam facing similar concerns. Although there has been some progress in lowering its incidence and mortality rates, a comprehensive understanding of long-term trends and the factors driving these changes remains limited.

Objective

This study aimed to analyze the burden and risk factors of cervical cancer in Vietnam over a 3-decade period, from 1990 to 2021 with projection to 2050.

Study design

Our study used data from the Global Burden of Disease (GBD) 2021 estimates, developed by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. This dataset includes metrics such as incidence, prevalence, mortality, and disability-adjusted life years (DALYs), all presented as age-standardized rates (ASRs) per 100,000 individuals. We analyzed trends from 1990 to 2021 and projections for 2022 to 2050 using the Joinpoint regression model. Additionally, we examined ASRs for death and DALYs attributed to cervical cancer-related risk factors.

Results

In 2021, cervical cancer accounted for approximately 4369 deaths (95% UI: 3345–5713) in Vietnam, with ASRs for incidence, prevalence, and mortality at 16.50 per 100,000 (95% UI: 12.49–21.83), 88.11 per 100,000 (95% UI: 65.32–116.75), and 7.66 per 100,000 (95% UI: 5.90–9.94), respectively. From 1990 to 2021, trends in incidence, DALYs, and mortality followed 3 phases: a decrease in incidence from 1990 to 1992 (APC: –2.42%, 95% CI: –3.56 to –0.85), an increase from 1992 to 1996 (APC: 2.69%, 95% CI: 2.09–3.65), and a subsequent decrease from 1996 to 2008 (APC: -0.68%, 95% CI: –0.86 to –0.57), with no significant change from 2008 to 2021. Projections from 2022 to 2050 suggest an all-age DALYs rate of 147.55 (95% UI: 105.14–198.31) in 2050, with an expected rise until 2039 followed by a decline, reflecting an annual percent change of –0.2% (95% CI: –0.07 to –0.55). Major risk factors for cervical cancer in Vietnam include smoking and unsafe sexual practices, with associated age-standardized mortality rates of 0.31 (95% UI: 0.16–0.53) and 7.66 (95% CI: 5.89–9.80) per year, respectively.

Conclusion

The study reveals that, despite some progress in reducing the incidence, mortality, and DALYs associated with cervical cancer in Vietnam over the past 3 decades, the overall burden remains substantial. This study underscores the impact of key risk factors, including smoking and unsafe sex. Future research is needed to evaluate effective interventions and healthcare policies that could reduce the burden of cervical cancer and improve women’s health outcomes in Vietnam.
宫颈癌仍然是一个重大的全球健康挑战,越南也面临着类似的问题。虽然在降低其发病率和死亡率方面取得了一些进展,但对长期趋势和推动这些变化的因素的全面了解仍然有限。目的本研究旨在分析1990年至2021年(预计到2050年)30年间越南宫颈癌的负担和危险因素。我们的研究使用了由华盛顿大学健康指标与评估研究所(IHME)开发的2021年全球疾病负担(GBD)估计数据。该数据集包括发病率、患病率、死亡率和残疾调整生命年(DALYs)等指标,所有指标均以每10万人的年龄标准化率(ASRs)表示。我们使用Joinpoint回归模型分析了1990年至2021年的趋势和2022年至2050年的预测。此外,我们还检查了asr与宫颈癌相关危险因素导致的死亡和DALYs。结果2021年,越南宫颈癌死亡人数约为4369人(95% UI: 3345-5713),发病率、患病率和死亡率的asr分别为16.50 / 10万(95% UI: 12.49-21.83)、88.11 / 10万(95% UI: 65.32-116.75)和7.66 / 10万(95% UI: 5.90-9.94)。从1990年到2021年,发病率、DALYs和死亡率的趋势经历了3个阶段:1990年至1992年发病率下降(APC: -2.42%, 95% CI: -3.56至-0.85),1992年至1996年发病率上升(APC: 2.69%, 95% CI: 2.09-3.65),随后1996年至2008年发病率下降(APC: -0.68%, 95% CI: -0.86至-0.57),2008年至2021年无显著变化。从2022年到2050年的预测表明,2050年所有年龄的DALYs率为147.55 (95% UI: 105.14-198.31),预计到2039年将上升,随后下降,反映出每年0.2%的百分比变化(95% CI: -0.07至-0.55)。越南宫颈癌的主要危险因素包括吸烟和不安全性行为,相关的年龄标准化死亡率分别为每年0.31(95%置信区间:0.16-0.53)和7.66(95%置信区间:5.89-9.80)。研究表明,尽管在过去30年中越南在降低宫颈癌的发病率、死亡率和DALYs方面取得了一些进展,但总体负担仍然很大。这项研究强调了主要风险因素的影响,包括吸烟和不安全性行为。未来的研究需要评估有效的干预措施和保健政策,以减轻越南宫颈癌的负担并改善妇女的健康结果。
{"title":"Burden and risk factors of cervical cancer in Vietnam from 1990 to 2021 and forecasting to 2050—a systematic analysis from global burden disease","authors":"Bao Huy Le MD ,&nbsp;Thao-Ngan Nguyen Pham MD ,&nbsp;Huong-Dung Thi Nguyen MD ,&nbsp;Tri Cuong Phan MD ,&nbsp;Han My Nguyen Le ,&nbsp;Thien Tan Tri Tai Truyen MD ,&nbsp;Tam Duc Lam MD, PhD","doi":"10.1016/j.xagr.2025.100526","DOIUrl":"10.1016/j.xagr.2025.100526","url":null,"abstract":"<div><h3>Background</h3><div>Cervical cancer continues to be a significant global health challenge, with Vietnam facing similar concerns. Although there has been some progress in lowering its incidence and mortality rates, a comprehensive understanding of long-term trends and the factors driving these changes remains limited.</div></div><div><h3>Objective</h3><div>This study aimed to analyze the burden and risk factors of cervical cancer in Vietnam over a 3-decade period, from 1990 to 2021 with projection to 2050.</div></div><div><h3>Study design</h3><div>Our study used data from the Global Burden of Disease (GBD) 2021 estimates, developed by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. This dataset includes metrics such as incidence, prevalence, mortality, and disability-adjusted life years (DALYs), all presented as age-standardized rates (ASRs) per 100,000 individuals. We analyzed trends from 1990 to 2021 and projections for 2022 to 2050 using the Joinpoint regression model. Additionally, we examined ASRs for death and DALYs attributed to cervical cancer-related risk factors.</div></div><div><h3>Results</h3><div>In 2021, cervical cancer accounted for approximately 4369 deaths (95% UI: 3345–5713) in Vietnam, with ASRs for incidence, prevalence, and mortality at 16.50 per 100,000 (95% UI: 12.49–21.83), 88.11 per 100,000 (95% UI: 65.32–116.75), and 7.66 per 100,000 (95% UI: 5.90–9.94), respectively. From 1990 to 2021, trends in incidence, DALYs, and mortality followed 3 phases: a decrease in incidence from 1990 to 1992 (APC: –2.42%, 95% CI: –3.56 to –0.85), an increase from 1992 to 1996 (APC: 2.69%, 95% CI: 2.09–3.65), and a subsequent decrease from 1996 to 2008 (APC: -0.68%, 95% CI: –0.86 to –0.57), with no significant change from 2008 to 2021. Projections from 2022 to 2050 suggest an all-age DALYs rate of 147.55 (95% UI: 105.14–198.31) in 2050, with an expected rise until 2039 followed by a decline, reflecting an annual percent change of –0.2% (95% CI: –0.07 to –0.55). Major risk factors for cervical cancer in Vietnam include smoking and unsafe sexual practices, with associated age-standardized mortality rates of 0.31 (95% UI: 0.16–0.53) and 7.66 (95% CI: 5.89–9.80) per year, respectively.</div></div><div><h3>Conclusion</h3><div>The study reveals that, despite some progress in reducing the incidence, mortality, and DALYs associated with cervical cancer in Vietnam over the past 3 decades, the overall burden remains substantial. This study underscores the impact of key risk factors, including smoking and unsafe sex. Future research is needed to evaluate effective interventions and healthcare policies that could reduce the burden of cervical cancer and improve women’s health outcomes in Vietnam.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100526"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144502371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective determination of heat shock protein serum levels in Saskatchewan women during pregnancy 萨斯喀彻温省妇女妊娠期热休克蛋白血清水平的前瞻性测定
Pub Date : 2025-06-04 DOI: 10.1016/j.xagr.2025.100533
Lindsey Broberg MD , Ewa I. Miskiewicz PhD , Jocelyne Martel MD , Daniel J. MacPhee PhD

BACKGROUND

The stress proteins, heat shock protein 27, heat shock protein 70, and αB-crystallin, have all been detected in human serum under normal and disease conditions. Heat shock protein 70 serum levels are known to increase in women with advancing pregnancy, but heat shock protein 27, heat shock protein 70, and αB-crystallin have never been assessed prospectively in pregnancy and labor.

OBJECTIVE

This study aimed to determine the serum levels of heat shock protein 27, heat shock protein 70, and αB-crystallin in women during pregnancy to assess whether the levels increase significantly over time and particularly at term and/or labor.

STUDY DESIGN

A prospective cohort pilot study of serum levels of heat shock protein 27, heat shock protein 70, and αB-crystallin in Saskatoon-area women with singleton pregnancies using enzyme-linked immunosorbent assays was conducted. Serum samples were collected from each patient at 3 periods: <14 weeks of gestation, 22 to 33 weeks of gestation at glucose screening, and at term nonlabor/active labor. The enzyme-linked immunosorbent assay data were subjected to D’Agostino and Pearson tests for normality. If data were not normally distributed, Friedman tests followed by Dunn multiple comparisons tests were performed. If data were normally distributed, they were subjected to repeated measures one-way analysis of variance, followed by Tukey multiple comparisons tests. In addition, a Spearman correlation analysis of heat shock protein levels with increasing gestational age was performed. All data were assessed and graphed using GraphPad Prism software.

RESULTS

Heat shock protein 27 levels were significantly elevated at term/labor compared with the 2 earlier time points assessed (Dunn multiple comparisons test: P<.0001 compared with <14 weeks of gestation and P=.0014 compared with 22–33 weeks of gestation). In addition, heat shock protein 70 serum levels were significantly elevated at term/labor compared with earlier time points (Dunn multiple comparisons test: P=.0005 compared with <14 weeks of gestation and P=.0179 compared with 22–33 weeks of gestation). In contrast, αB-crystallin levels were not significantly different throughout pregnancy. When the serum levels of the heat shock proteins throughout pregnancy were separately examined in the prospective cohorts who were sampled at term or at active spontaneous or induced labor, heat shock protein 27 levels were still significantly elevated at term (Tukey multiple comparisons test: P=.003 compared with <14 weeks of gestation and P=.031 compared with 22–33 weeks of gestation) or at labor (Tukey multiple comparisons test: P<.0001 compared with <14 and 22–33 weeks of gestation). Of note, heat shock protein 27 levels were significantly elevated at term compared with at labor (3.949±0
背景:在正常和疾病条件下,人血清中均检测到应激蛋白、热休克蛋白27、热休克蛋白70和α b -结晶蛋白。已知妊娠早期妇女血清中热休克蛋白70水平升高,但热休克蛋白27、热休克蛋白70和α b -晶体蛋白从未在妊娠和分娩中进行前瞻性评估。目的:本研究旨在测定妊娠妇女血清中热休克蛋白27、热休克蛋白70和α b -结晶蛋白的水平,以评估其水平是否随着时间的推移而显著增加,特别是在足月和/或分娩时。研究设计采用酶联免疫吸附法对萨斯卡通地区单胎妊娠妇女血清热休克蛋白27、热休克蛋白70和α b -结晶蛋白水平进行前瞻性队列试验研究。在妊娠14周、妊娠22 ~ 33周葡萄糖筛查和足月非产程/活产时采集每位患者的血清样本。酶联免疫吸附试验数据经D 'Agostino和Pearson检验是否正常。如果数据不是正态分布,则进行Friedman检验,然后进行Dunn多重比较检验。如果数据为正态分布,则对其进行重复测量、单因素方差分析,然后进行Tukey多重比较检验。此外,热休克蛋白水平与胎龄增加的Spearman相关性分析进行。使用GraphPad Prism软件对所有数据进行评估和绘图。结果与前2个评估时间点相比,足月/分娩时休克蛋白27水平显著升高(Dunn多重比较试验:P<;与妊娠14周<; 0001相比,P=。与妊娠22-33周相比,0.0014)。此外,与早期时间点相比,足月/分娩时血清热休克蛋白70水平显著升高(Dunn多重比较检验:P=。与妊娠14周相比,P=。0179与22-33周相比)。相比之下,α b -结晶蛋白水平在整个妊娠期间无显著差异。当在足月或主动自然分娩或引产的前瞻性队列中分别检测整个妊娠期间的血清热休克蛋白水平时,热休克蛋白27水平在足月仍显着升高(Tukey多重比较检验:P=。003与妊娠14周相比P=。031与妊娠22-33周比较)或分娩时(Tukey多重比较检验:P<;0001与妊娠14周和22-33周相比)。值得注意的是,与分娩时相比,足月时热休克蛋白27水平显著升高(分别为3.949±0.622 vs 2.139±0.241);韦尔奇P = .0211)。与妊娠14周相比,热休克蛋白70水平仅在足月(Dunn P= 0.029)或分娩时(Tukey P= 0.015)显著升高。在这两个队列中,α b -晶体蛋白水平在整个妊娠期间无显著差异。总的来说,胎龄与热休克蛋白27或热休克蛋白70血清浓度之间存在显著的正相关,无论是作为一个群体还是在足月或分娩时取样的患者单独队列进行检测。结论足月和(或)分娩期孕妇血清热休克蛋白27和热休克蛋白70水平较妊娠早期显著升高,且与胎龄呈正相关。然而,与临产时相比,足月时热休克蛋白27的水平也显著升高,从而确定这种小的热休克蛋白是临产的候选生物标志物。这种生物标志物对于筛查远离城市分娩中心的农村足月孕妇很有价值,可以最大限度地减少旅行、经济成本和产妇压力。
{"title":"Prospective determination of heat shock protein serum levels in Saskatchewan women during pregnancy","authors":"Lindsey Broberg MD ,&nbsp;Ewa I. Miskiewicz PhD ,&nbsp;Jocelyne Martel MD ,&nbsp;Daniel J. MacPhee PhD","doi":"10.1016/j.xagr.2025.100533","DOIUrl":"10.1016/j.xagr.2025.100533","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>The stress proteins, heat shock protein 27, heat shock protein 70, and αB-crystallin, have all been detected in human serum under normal and disease conditions. Heat shock protein 70 serum levels are known to increase in women with advancing pregnancy, but heat shock protein 27, heat shock protein 70, and αB-crystallin have never been assessed prospectively in pregnancy and labor.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to determine the serum levels of heat shock protein 27, heat shock protein 70, and αB-crystallin in women during pregnancy to assess whether the levels increase significantly over time and particularly at term and/or labor.</div></div><div><h3>STUDY DESIGN</h3><div>A prospective cohort pilot study of serum levels of heat shock protein 27, heat shock protein 70, and αB-crystallin in Saskatoon-area women with singleton pregnancies using enzyme-linked immunosorbent assays was conducted. Serum samples were collected from each patient at 3 periods: &lt;14 weeks of gestation, 22 to 33 weeks of gestation at glucose screening, and at term nonlabor/active labor. The enzyme-linked immunosorbent assay data were subjected to D’Agostino and Pearson tests for normality. If data were not normally distributed, Friedman tests followed by Dunn multiple comparisons tests were performed. If data were normally distributed, they were subjected to repeated measures one-way analysis of variance, followed by Tukey multiple comparisons tests. In addition, a Spearman correlation analysis of heat shock protein levels with increasing gestational age was performed. All data were assessed and graphed using GraphPad Prism software.</div></div><div><h3>RESULTS</h3><div>Heat shock protein 27 levels were significantly elevated at term/labor compared with the 2 earlier time points assessed (Dunn multiple comparisons test: <em>P</em>&lt;.0001 compared with &lt;14 weeks of gestation and <em>P</em>=.0014 compared with 22–33 weeks of gestation). In addition, heat shock protein 70 serum levels were significantly elevated at term/labor compared with earlier time points (Dunn multiple comparisons test: <em>P</em>=.0005 compared with &lt;14 weeks of gestation and <em>P</em>=.0179 compared with 22–33 weeks of gestation). In contrast, αB-crystallin levels were not significantly different throughout pregnancy. When the serum levels of the heat shock proteins throughout pregnancy were separately examined in the prospective cohorts who were sampled at term or at active spontaneous or induced labor, heat shock protein 27 levels were still significantly elevated at term (Tukey multiple comparisons test: <em>P</em>=.003 compared with &lt;14 weeks of gestation and <em>P</em>=.031 compared with 22–33 weeks of gestation) or at labor (Tukey multiple comparisons test: <em>P</em>&lt;.0001 compared with &lt;14 and 22–33 weeks of gestation). Of note, heat shock protein 27 levels were significantly elevated at term compared with at labor (3.949±0","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100533"},"PeriodicalIF":0.0,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144588661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indiscriminate antibiotic prescribing for nonspecific symptoms perpetuates gender-based healthcare inequities 不分青红皂白地为非特异性症状开抗生素处方,使基于性别的医疗不平等永久化
Pub Date : 2025-06-02 DOI: 10.1016/j.xagr.2025.100524
Alec Szlachta-McGinn MD , Lynn Stothers MD, MHS , A. Lenore Ackerman MD, PhD
Urinary tract infection is among the most common bacterial infection among adults, and women are significantly more likely to experience urinary tract infection than men. The prevalence of urinary tract infection in women increases with age, as does the prevalence of noninfectious lower urinary tract symptoms and asymptomatic bacterial colonization of the urinary tract, known as asymptomatic bacteriuria. Distinguishing among these 3 entities is challenging without a complete clinical evaluation, including history, physical examination, and urine culture data. Existing literature demonstrates high misclassification of nonspecific symptoms, such as urinary tract infection, among women. In addition, less than one-fifth of diagnoses meet evidence-based criteria for urinary tract infection. Therefore, women are burdened by several healthcare inequities, including delays in care for potentially life-threatening conditions, antibiotic resistance and antibiotic-associated adverse events because of overreliance on antibiotics for noninfectious symptoms, and distrust of medical care. Profit-driven pressures imposed by our healthcare system, which reward providers for increasing clinical volume at the expense of quality patient-provider interactions, are a major culprit driving these inequities. In addition, lack of provider knowledge regarding urinary tract infection–confusable diagnoses, discomfort with pelvic examinations, and inappropriate use of automated question-based algorithms to diagnose and treat urinary tract infection are to blame. An evidence-based approach incorporating a focused history and physical examination that is concordant with the patient’s chief complaint in addition to urine culture data only in cases of suspected urinary tract infection is the only way to reduce urinary tract infection–related healthcare inequities unfairly confronting women.
尿路感染是成年人中最常见的细菌感染之一,女性比男性更容易患尿路感染。女性尿路感染的患病率随着年龄的增长而增加,非感染性下尿路症状和尿路无症状细菌定植(称为无症状性细菌尿)的患病率也在增加。如果没有完整的临床评估,包括病史、体格检查和尿液培养数据,区分这三种实体是具有挑战性的。现有文献表明,在女性中,非特异性症状(如尿路感染)的错误分类很高。此外,不到五分之一的诊断符合基于证据的尿路感染标准。因此,妇女承受着若干医疗保健不平等的负担,包括对可能危及生命的疾病的护理延误、抗生素耐药性和因过度依赖抗生素治疗非传染性症状而导致的抗生素相关不良事件,以及对医疗保健的不信任。我们的医疗保健系统所施加的利润驱动的压力是造成这些不平等的罪魁祸首。医疗保健系统以牺牲患者与提供者之间的优质互动为代价,奖励提供者增加临床数量。此外,缺乏提供者对尿路感染的知识——易混淆的诊断,盆腔检查的不适,以及不恰当地使用基于问题的自动算法来诊断和治疗尿路感染是罪魁祸首。以证据为基础的方法,结合与患者主诉一致的重点病史和体格检查,以及仅在怀疑尿路感染的情况下的尿液培养数据,是减少与尿路感染相关的医疗不公平对待妇女的唯一途径。
{"title":"Indiscriminate antibiotic prescribing for nonspecific symptoms perpetuates gender-based healthcare inequities","authors":"Alec Szlachta-McGinn MD ,&nbsp;Lynn Stothers MD, MHS ,&nbsp;A. Lenore Ackerman MD, PhD","doi":"10.1016/j.xagr.2025.100524","DOIUrl":"10.1016/j.xagr.2025.100524","url":null,"abstract":"<div><div>Urinary tract infection is among the most common bacterial infection among adults, and women are significantly more likely to experience urinary tract infection than men. The prevalence of urinary tract infection in women increases with age, as does the prevalence of noninfectious lower urinary tract symptoms and asymptomatic bacterial colonization of the urinary tract, known as asymptomatic bacteriuria. Distinguishing among these 3 entities is challenging without a complete clinical evaluation, including history, physical examination, and urine culture data. Existing literature demonstrates high misclassification of nonspecific symptoms, such as urinary tract infection, among women. In addition, less than one-fifth of diagnoses meet evidence-based criteria for urinary tract infection. Therefore, women are burdened by several healthcare inequities, including delays in care for potentially life-threatening conditions, antibiotic resistance and antibiotic-associated adverse events because of overreliance on antibiotics for noninfectious symptoms, and distrust of medical care. Profit-driven pressures imposed by our healthcare system, which reward providers for increasing clinical volume at the expense of quality patient-provider interactions, are a major culprit driving these inequities. In addition, lack of provider knowledge regarding urinary tract infection–confusable diagnoses, discomfort with pelvic examinations, and inappropriate use of automated question-based algorithms to diagnose and treat urinary tract infection are to blame. An evidence-based approach incorporating a focused history and physical examination that is concordant with the patient’s chief complaint in addition to urine culture data only in cases of suspected urinary tract infection is the only way to reduce urinary tract infection–related healthcare inequities unfairly confronting women.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100524"},"PeriodicalIF":0.0,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-indicated cerclage: does expedited placement prolong gestation? 超声提示环切术:加速放置会延长妊娠期吗?
Pub Date : 2025-05-30 DOI: 10.1016/j.xagr.2025.100523
Sarah H. Abelman MD , Frank I. Jackson DO , Nathan A. Keller MD , Julie Chen BBA , Luis A. Bracero MD , Cara S. Wetcher MD , Matthew J. Blitz MD, MBA

Background

There is no clear consensus on the urgency of ultrasound-indicated cerclage placement after sonographic diagnosis of a short cervix, and it remains uncertain whether immediate cerclage placement prolongs gestation and improves pregnancy outcomes compared to scheduling within a reasonable timeframe.

Objective

This study aimed to determine whether the time interval between the sonographic diagnosis of a short cervix and transvaginal cerclage placement is associated with gestational age at delivery and preterm birth.

Study Design

This retrospective cohort study included all patients who received an ultrasound-indicated cerclage between January 2018 and December 2023 within a large New York health system. Patients were categorized into two groups: those with a history of preterm birth and a short cervix (<25 mm) and those with no prior preterm birth but a very short cervix (<10 mm). The primary exposure was the time interval between diagnosis of a short cervix (ie, decision for cerclage) and cerclage placement, with expedited placement defined as within 1 day for patients without prior preterm birth, and within 5 days for those with prior preterm birth. These cutoffs were determined based on the median time-to-cerclage (days) observed within our study population for each cohort and rounded to the nearest day. The primary outcome was gestational age at delivery, with secondary outcomes including latency to delivery, as well as preterm birth at <37, <34, and <32 weeks. Statistical analyses included linear mixed model regression and multivariate logistic regression, adjusting for body mass index, gestational age at diagnosis, and shortest cervical length prior to cerclage. Data were analyzed using R version 4.3.1. Statistical significance was defined as P<.05.

Results

A total of 125 patients were included, with 83 having a cervical length <10 mm and no prior preterm birth, and 42 having a cervical length <25 mm with a history of preterm birth. In the group without a prior preterm birth, the mean cervical length before cerclage was 6.3±2.4 mm, and the mean gestational age at cerclage placement was 21.0±1.7 weeks. Overall, 74.7% received expedited cerclage placement (≤1 day), while 25.3% underwent routine placement. Gestational age at delivery and preterm birth rates were similar between the expedited and routine placement groups. In the group with a history of preterm birth, the mean cervical length before cerclage was 18.2±5.8 mm, with cerclage placed at a mean gestational age of 19.8±2.6 weeks. Overall, 45.2% underwent expedited placement (≤5 days), while 54.8% had routine placement. A statistically significant difference in gestational age at delivery was observed between groups (36.9±2.5 weeks vs 36.9±3.0 weeks, P=.04), but this difference was not clinically meaningful.

Concl

超声诊断短宫颈后,超声指示的环切置入的紧迫性尚无明确的共识,与在合理的时间范围内安排相比,立即环切置入是否能延长妊娠期并改善妊娠结局仍不确定。目的本研究旨在确定超声诊断宫颈短和阴道环切放置之间的时间间隔是否与分娩时胎龄和早产有关。本回顾性队列研究纳入了纽约大型卫生系统中2018年1月至2023年12月期间接受超声指示环切术的所有患者。患者被分为两组:有早产史且宫颈短(25毫米)的患者和没有早产但宫颈短(10毫米)的患者。主要暴露是诊断宫颈短(即决定进行环切)和环切放置之间的时间间隔,对于没有早产的患者,加速放置定义为1天内,对于有早产的患者,加速放置定义为5天内。这些截止点是根据我们在每个队列的研究人群中观察到的到循环的中位数时间(天)确定的,并四舍五入到最近的一天。主要终点是分娩时的胎龄,次要终点包括分娩潜伏期,以及37周、34周和32周时的早产。统计分析包括线性混合模型回归和多元逻辑回归,调整体重指数、诊断时胎龄和结扎前最短宫颈长度。数据分析采用R 4.3.1版本。统计学意义定义为P<; 0.05。结果共纳入125例患者,其中颈长10mm无早产史83例,颈长25mm有早产史42例。无早产史组,环扎术前平均宫颈长度为6.3±2.4 mm,环扎术放置时平均胎龄为21.0±1.7周。总体而言,74.7%的患者接受了加速环切置入(≤1天),而25.3%的患者接受了常规置入。加速组和常规组的分娩胎龄和早产率相似。有早产史的组,结扎术前平均宫颈长度为18.2±5.8 mm,结扎术的平均胎龄为19.8±2.6周。总体而言,45.2%的患者接受了加速安置(≤5天),而54.8%的患者接受了常规安置。两组分娩胎龄比较差异有统计学意义(36.9±2.5周vs 36.9±3.0周,P= 0.04),但差异无临床意义。综上所述,两组患者的妊娠结局均未见加速环扎术的改善,提示无需立即进行环扎术,在合理的时间范围内进行环扎术是合适的。
{"title":"Ultrasound-indicated cerclage: does expedited placement prolong gestation?","authors":"Sarah H. Abelman MD ,&nbsp;Frank I. Jackson DO ,&nbsp;Nathan A. Keller MD ,&nbsp;Julie Chen BBA ,&nbsp;Luis A. Bracero MD ,&nbsp;Cara S. Wetcher MD ,&nbsp;Matthew J. Blitz MD, MBA","doi":"10.1016/j.xagr.2025.100523","DOIUrl":"10.1016/j.xagr.2025.100523","url":null,"abstract":"<div><h3>Background</h3><div>There is no clear consensus on the urgency of ultrasound-indicated cerclage placement after sonographic diagnosis of a short cervix, and it remains uncertain whether immediate cerclage placement prolongs gestation and improves pregnancy outcomes compared to scheduling within a reasonable timeframe.</div></div><div><h3>Objective</h3><div>This study aimed to determine whether the time interval between the sonographic diagnosis of a short cervix and transvaginal cerclage placement is associated with gestational age at delivery and preterm birth.</div></div><div><h3>Study Design</h3><div>This retrospective cohort study included all patients who received an ultrasound-indicated cerclage between January 2018 and December 2023 within a large New York health system. Patients were categorized into two groups: those with a history of preterm birth and a short cervix (&lt;25 mm) and those with no prior preterm birth but a very short cervix (&lt;10 mm). The primary exposure was the time interval between diagnosis of a short cervix (ie, decision for cerclage) and cerclage placement, with expedited placement defined as within 1 day for patients without prior preterm birth, and within 5 days for those with prior preterm birth. These cutoffs were determined based on the median time-to-cerclage (days) observed within our study population for each cohort and rounded to the nearest day. The primary outcome was gestational age at delivery, with secondary outcomes including latency to delivery, as well as preterm birth at &lt;37, &lt;34, and &lt;32 weeks. Statistical analyses included linear mixed model regression and multivariate logistic regression, adjusting for body mass index, gestational age at diagnosis, and shortest cervical length prior to cerclage. Data were analyzed using R version 4.3.1. Statistical significance was defined as <em>P</em>&lt;.05.</div></div><div><h3>Results</h3><div>A total of 125 patients were included, with 83 having a cervical length &lt;10 mm and no prior preterm birth, and 42 having a cervical length &lt;25 mm with a history of preterm birth. In the group without a prior preterm birth, the mean cervical length before cerclage was 6.3±2.4 mm, and the mean gestational age at cerclage placement was 21.0±1.7 weeks. Overall, 74.7% received expedited cerclage placement (≤1 day), while 25.3% underwent routine placement. Gestational age at delivery and preterm birth rates were similar between the expedited and routine placement groups. In the group with a history of preterm birth, the mean cervical length before cerclage was 18.2±5.8 mm, with cerclage placed at a mean gestational age of 19.8±2.6 weeks. Overall, 45.2% underwent expedited placement (≤5 days), while 54.8% had routine placement. A statistically significant difference in gestational age at delivery was observed between groups (36.9±2.5 weeks vs 36.9±3.0 weeks, <em>P</em>=.04), but this difference was not clinically meaningful.</div></div><div><h3>Concl","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100523"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of newly diagnosed essential hypertension within one year postpartum: a systematic review and meta-analysis 产后一年内新诊断原发性高血压的患病率:系统回顾和荟萃分析
Pub Date : 2025-05-30 DOI: 10.1016/j.xagr.2025.100519
Jennifer D. Kaminker , Alexandra MacMaster , Jessica Pudwell , Kira King , Graeme N. Smith

Objective

Pregnancy induces a state of cardiovascular stress and can lead to long-lasting effects irrespective of complications in pregnancy. However, the magnitude of these effects needs to be clarified. This study seeks to determine the prevalence of newly diagnosed essential hypertension within one year postpartum among the obstetric population who experienced uncomplicated pregnancies.

Data sources

A comprehensive search of the databases MEDLINE, Cochrane Central Register of Controlled Clinical Trials, EMBASE, Web of Science, and CINAHL was conducted for studies published up to March 2023.

Study eligibility criteria

Studies that assessed healthy individuals between 12 weeks and one year postpartum with newly diagnosed essential hypertension (≥140/90) and without pregnancy complications were included. Case studies, systematic reviews, and meta-analyses were excluded, along with studies involving pregnant patients who were either less than three months or more than one year postpartum, those with pre-existing hypertension or pregnancy complications, or those with pre-existing medical conditions.

Study appraisal and synthesis methods

Meta-analyses using random-effects models calculated pooled prevalence estimates and examined mean arterial pressure, systolic blood pressure, and diastolic blood pressure. Subgroup analyses considered the timing of blood pressure assessment, geographical location, and the presence of interventions.

Results

In eight studies with 3070 participants, the prevalence of newly diagnosed hypertension was 2.96% (95% confidence interval [CI], 1.15%–7.43%; I², 80%). No significant differences were observed in the subgroup analyses. Across 30 studies with 1782 individuals, the average systolic blood pressure was 109.88 mmHg (95% CI, 108–111.75; I², 92.2%), and diastolic blood pressure was 70.99 mmHg (95% CI, 68.84–73.14; I², 95.7%). In 12 studies with 339 individuals, the average mean arterial pressure was 82.01 mmHg (95% CI, 79.84–84.19; I², 93.6%).

Conclusions

These findings suggest that nearly 3 in 100 healthy individuals with uncomplicated pregnancies are diagnosed with de novo essential hypertension within one year postpartum. This underscores the need to extend cardiovascular screening to all postpartum individuals for one year, regardless of medical or pregnancy history.
目的妊娠诱发心血管应激状态,不论妊娠期是否有并发症,均可导致长期影响。然而,这些影响的程度需要澄清。本研究旨在确定无并发症妊娠的产科人群产后一年内新诊断的原发性高血压的患病率。数据来源对MEDLINE、Cochrane中央对照临床试验登记册、EMBASE、Web of Science和CINAHL数据库进行了全面检索,检索截止到2023年3月发表的研究。研究入选标准:研究纳入了产后12周至1年内新诊断为原发性高血压(≥140/90)且无妊娠并发症的健康个体。排除了案例研究、系统评价和荟萃分析,以及涉及产后不到三个月或一年以上的孕妇、已有高血压或妊娠并发症的孕妇或已有疾病的孕妇的研究。研究评价和综合方法:采用随机效应模型进行meta分析,计算合并患病率估计值,并检查平均动脉压、收缩压和舒张压。亚组分析考虑了血压评估的时间、地理位置和干预措施的存在。结果8项研究共3070名受试者,新诊断高血压的患病率为2.96%(95%可信区间[CI], 1.15% ~ 7.43%;我²,80%)。在亚组分析中未观察到显著差异。在涉及1782人的30项研究中,平均收缩压为109.88 mmHg (95% CI, 108-111.75;I²,92.2%),舒张压为70.99 mmHg (95% CI, 68.84-73.14;我²,95.7%)。在涉及339人的12项研究中,平均动脉压为82.01 mmHg (95% CI, 79.84-84.19;我²,93.6%)。结论无并发症的健康孕妇在产后1年内有近3 / 100的人被诊断为新生原发性高血压。这强调了将心血管筛查扩展到所有产后个体一年的必要性,无论病史或妊娠史如何。
{"title":"Prevalence of newly diagnosed essential hypertension within one year postpartum: a systematic review and meta-analysis","authors":"Jennifer D. Kaminker ,&nbsp;Alexandra MacMaster ,&nbsp;Jessica Pudwell ,&nbsp;Kira King ,&nbsp;Graeme N. Smith","doi":"10.1016/j.xagr.2025.100519","DOIUrl":"10.1016/j.xagr.2025.100519","url":null,"abstract":"<div><h3>Objective</h3><div>Pregnancy induces a state of cardiovascular stress and can lead to long-lasting effects irrespective of complications in pregnancy. However, the magnitude of these effects needs to be clarified. This study seeks to determine the prevalence of newly diagnosed essential hypertension within one year postpartum among the obstetric population who experienced uncomplicated pregnancies.</div></div><div><h3>Data sources</h3><div>A comprehensive search of the databases MEDLINE, Cochrane Central Register of Controlled Clinical Trials, EMBASE, Web of Science, and CINAHL was conducted for studies published up to March 2023.</div></div><div><h3>Study eligibility criteria</h3><div>Studies that assessed healthy individuals between 12 weeks and one year postpartum with newly diagnosed essential hypertension (≥140/90) and without pregnancy complications were included. Case studies, systematic reviews, and meta-analyses were excluded, along with studies involving pregnant patients who were either less than three months or more than one year postpartum, those with pre-existing hypertension or pregnancy complications, or those with pre-existing medical conditions.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>Meta-analyses using random-effects models calculated pooled prevalence estimates and examined mean arterial pressure, systolic blood pressure, and diastolic blood pressure. Subgroup analyses considered the timing of blood pressure assessment, geographical location, and the presence of interventions.</div></div><div><h3>Results</h3><div>In eight studies with 3070 participants, the prevalence of newly diagnosed hypertension was 2.96% (95% confidence interval [CI], 1.15%–7.43%; I², 80%). No significant differences were observed in the subgroup analyses. Across 30 studies with 1782 individuals, the average systolic blood pressure was 109.88 mmHg (95% CI, 108–111.75; I², 92.2%), and diastolic blood pressure was 70.99 mmHg (95% CI, 68.84–73.14; I², 95.7%). In 12 studies with 339 individuals, the average mean arterial pressure was 82.01 mmHg (95% CI, 79.84–84.19; I², 93.6%).</div></div><div><h3>Conclusions</h3><div>These findings suggest that nearly 3 in 100 healthy individuals with uncomplicated pregnancies are diagnosed with de novo essential hypertension within one year postpartum. This underscores the need to extend cardiovascular screening to all postpartum individuals for one year, regardless of medical or pregnancy history.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100519"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144480392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antenatal experiences of pregnant women with cardiac conditions: a systematic review and meta-synthesis 有心脏疾病的孕妇的产前经历:一项系统回顾和综合
Pub Date : 2025-05-28 DOI: 10.1016/j.xagr.2025.100522
Jasmine X. Kiley BSc , Annabelle Corlett BA , Emma Mitchell-Sparke MPhil , Brittany Jasper MD , Tabitha Wishlade MSc , Catriona Bhagra MD , Sara Wetzler MD , Catherine E. Aiken MBBChir, PhD

Objective

Cardiovascular conditions are the leading cause of maternal mortality in high-income countries. We aim to inform supportive care that addresses the needs of pregnant women with cardiac conditions.

Data Sources

Medline via Ovid, Embase via Ovid, CINAHL via Ebsco, PsychINFO via Ebsco, Scopus, Web of Science Core Collection, and ASSIA via Proquest were searched, database inception-June 2024.

Study Eligibility Criteria

Studies with qualitative components describing experiences of pregnant women with any cardiac condition globally.

Study Appraisal and Synthesis Methods

The Critical Appraisal Skills Programme checklist for qualitative research was employed to perform quality assessment. Inductive coding and thematic analysis were conducted using NVivo software.

Results

Thirteen qualitative studies met the inclusion criteria for meta-synthesis. We identified 3 key themes pertaining to the pregnancy experience of women with cardiac conditions, including patient-provider risk perception matching, importance of communication, and peer influence. Women with established versus new cardiac diagnoses in pregnancy had differences in their experiences. Depending on their own perception of risk, women noted over-medicalization or dismissal by their providers. Our findings also showed that some women sought peer support through online support groups, which either provided a sense of community and hope, or were anxiety-inducing.

Conclusions

It is critical for women and providers to have nuanced and personalized discussions about the risk of cardiac conditions during pregnancy. Experience of pregnancy differs amongst women with new or pre-existing cardiac conditions and is based on women’s appraisal of their pregnancy’s risk level. Reaching an agreement in risk perception is crucial to strengthen the patient-provider relationship and provide a basis for women to feel secure during their pregnancy.
目的心血管疾病是高收入国家孕产妇死亡的主要原因。我们的目标是告知支持性护理,以满足患有心脏病的孕妇的需求。检索数据来源:检索medline(通过Ovid)、Embase(通过Ovid)、CINAHL(通过Ebsco)、PsychINFO(通过Ebsco)、Scopus、Web of Science Core Collection和ASSIA(通过Proquest),数据库建立至2024年6月。研究资格标准:采用定性成分描述全球任何心脏病孕妇经历的研究。研究评估和综合方法采用定性研究的关键评估技能程序检查表进行质量评估。采用NVivo软件进行归纳编码和专题分析。结果13项定性研究符合meta综合纳入标准。我们确定了与患有心脏病的妇女怀孕经历有关的3个关键主题,包括患者-提供者风险感知匹配、沟通的重要性和同伴影响。已确诊的孕妇与新确诊的孕妇在经历上存在差异。根据她们自己对风险的看法,妇女指出,她们的医疗服务提供者过度用药或解雇她们。我们的研究结果还表明,一些女性通过在线支持小组寻求同伴的支持,这些小组要么提供了一种社区感和希望,要么会引起焦虑。结论对于妇女和医疗服务提供者来说,就怀孕期间心脏疾病的风险进行细致入微的个性化讨论是至关重要的。患有新的或先前存在的心脏病的妇女的怀孕经历是不同的,这是基于妇女对其怀孕风险水平的评估。在风险认知方面达成一致对于加强医患关系和为妇女在怀孕期间感到安全提供基础至关重要。
{"title":"Antenatal experiences of pregnant women with cardiac conditions: a systematic review and meta-synthesis","authors":"Jasmine X. Kiley BSc ,&nbsp;Annabelle Corlett BA ,&nbsp;Emma Mitchell-Sparke MPhil ,&nbsp;Brittany Jasper MD ,&nbsp;Tabitha Wishlade MSc ,&nbsp;Catriona Bhagra MD ,&nbsp;Sara Wetzler MD ,&nbsp;Catherine E. Aiken MBBChir, PhD","doi":"10.1016/j.xagr.2025.100522","DOIUrl":"10.1016/j.xagr.2025.100522","url":null,"abstract":"<div><h3>Objective</h3><div>Cardiovascular conditions are the leading cause of maternal mortality in high-income countries. We aim to inform supportive care that addresses the needs of pregnant women with cardiac conditions.</div></div><div><h3>Data Sources</h3><div>Medline via Ovid, Embase via Ovid, CINAHL via Ebsco, PsychINFO via Ebsco, Scopus, Web of Science Core Collection, and ASSIA via Proquest were searched, database inception-June 2024.</div></div><div><h3>Study Eligibility Criteria</h3><div>Studies with qualitative components describing experiences of pregnant women with any cardiac condition globally.</div></div><div><h3>Study Appraisal and Synthesis Methods</h3><div>The Critical Appraisal Skills Programme checklist for qualitative research was employed to perform quality assessment. Inductive coding and thematic analysis were conducted using NVivo software.</div></div><div><h3>Results</h3><div>Thirteen qualitative studies met the inclusion criteria for meta-synthesis. We identified 3 key themes pertaining to the pregnancy experience of women with cardiac conditions, including patient-provider risk perception matching, importance of communication, and peer influence. Women with established versus new cardiac diagnoses in pregnancy had differences in their experiences. Depending on their own perception of risk, women noted over-medicalization or dismissal by their providers. Our findings also showed that some women sought peer support through online support groups, which either provided a sense of community and hope, or were anxiety-inducing.</div></div><div><h3>Conclusions</h3><div>It is critical for women and providers to have nuanced and personalized discussions about the risk of cardiac conditions during pregnancy. Experience of pregnancy differs amongst women with new or pre-existing cardiac conditions and is based on women’s appraisal of their pregnancy’s risk level. Reaching an agreement in risk perception is crucial to strengthen the patient-provider relationship and provide a basis for women to feel secure during their pregnancy.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100522"},"PeriodicalIF":0.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144322263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does obstetric violence influence institutional delivery utilization? Prevalence of fear of institutional delivery on subsequent pregnancy among mothers who gave birth in the past 12 months at Honkolo Wabe District, Arsi Zone Ethiopia, 2023 产科暴力是否影响机构分娩的利用?2023年埃塞俄比亚阿尔西区Honkolo Wabe区过去12个月内分娩的母亲对随后怀孕的机构分娩的恐惧程度
Pub Date : 2025-05-23 DOI: 10.1016/j.xagr.2025.100520
Solomon Seyife Alemu MSc , Getu Amsalu Erqu MSc , Dereje Diriba Woyessa MSc , Lema Fikadu Wedajo MSc

BACKGROUND

One of the issues that contribute to the increase in home births among mothers is the fear of giving birth in an institution. Although delivery services are free in Ethiopia, about half of women chose not to use them because they were afraid of giving birth in a hospital. Home deliveries are the leading cause of morbidity and mortality among mothers and newborns in Ethiopia. One of the major reasons why mothers choose not to give birth in medical facilities is due to fear of an institutional delivery. Nevertheless, no research has been conducted on Ethiopians’ fear of institutional delivery.

OBJECTIVE

This study aimed to assess the prevalence of fear of institutional delivery and associated factors among postnatal mothers.

STUDY DESIGN

Between May 1, 2023, and June 1, 2023, 423 postpartum mothers in Ethiopia’s Honkolo Wabe district participated in a cross-sectional survey. A straightforward random sampling procedure was used to choose study participants. Data were gathered using a standardized questionnaire that was pretested and given by an interviewer in person. To find factors linked to the fear of institutional delivery, bivariate and multivariate analyses were performed. A P value of <.05 with a 95% confidence interval was designated as the level of statistical significance.

RESULTS

The overall prevalence of fear of institutional delivery was 43.9% (95% confidence interval, 39.9%–48.2%). Obstetrical violence (adjusted odds ratio, 2.42 [95% confidence interval, 1.20–4.19]), number of children (adjusted odds ratio, 0.39 [95% confidence interval, 0.19–0.82]), poor knowledge on the importance of intuitional delivery (adjusted odds ratio, 2.20 [95% confidence interval, 1.39–3.49]), and a negative attitude toward skilled healthcare services (adjusted odds ratio, 2.13 [95% confidence interval, 1.15–3.94]) were significantly associated factors for fear of childbirth at health facilities.

CONCLUSION

Our study found that the prevalence of fear of institutional delivery is high. Therefore, healthcare providers, health extension workers, and other concerned bodies should work on increasing mothers’ knowledge the importance of institutional delivery and their awareness of skilled birth. Similarly, respectful maternity care should be performed in accordance with attracting mothers to health institutions.
背景造成母亲在家分娩人数增加的一个原因是害怕在医疗机构分娩。虽然埃塞俄比亚的分娩服务是免费的,但大约一半的妇女选择不使用这些服务,因为她们害怕在医院分娩。在埃塞俄比亚,在家分娩是母亲和新生儿发病和死亡的主要原因。母亲选择不在医疗机构分娩的一个主要原因是害怕在医院分娩。然而,还没有对埃塞俄比亚人对体制交付的恐惧进行过研究。目的本研究旨在评估产后母亲机构分娩恐惧的患病率及其相关因素。研究设计在2023年5月1日至2023年6月1日期间,埃塞俄比亚Honkolo Wabe地区的423名产后母亲参加了一项横断面调查。采用直接的随机抽样程序来选择研究参与者。数据是通过标准化的问卷收集的,问卷是预先测试的,并由采访者亲自给出。为了找到与机构交付恐惧相关的因素,进行了双变量和多变量分析。P值为<;以具有95%置信区间的0.05为具有统计学显著性的水平。结果机构分娩恐惧总体患病率为43.9%(95%可信区间为39.9% ~ 48.2%)。产科暴力(调整优势比,2.42[95%置信区间,1.20-4.19])、子女数量(调整优势比,0.39[95%置信区间,0.19-0.82])、对直觉分娩重要性认识不足(调整优势比,2.20[95%置信区间,1.39-3.49])、对熟练医疗服务持消极态度(调整优势比,2.13[95%置信区间,1.20 - 3.49])。[1.15-3.94])是害怕在医疗机构分娩的显著相关因素。结论本研究发现,医院分娩恐惧的患病率较高。因此,卫生保健提供者、卫生推广工作者和其他有关机构应努力提高母亲对机构分娩重要性的认识,并提高她们对熟练分娩的认识。同样,应按照吸引母亲到保健机构就诊的方式,提供尊重产妇的护理。
{"title":"Does obstetric violence influence institutional delivery utilization? Prevalence of fear of institutional delivery on subsequent pregnancy among mothers who gave birth in the past 12 months at Honkolo Wabe District, Arsi Zone Ethiopia, 2023","authors":"Solomon Seyife Alemu MSc ,&nbsp;Getu Amsalu Erqu MSc ,&nbsp;Dereje Diriba Woyessa MSc ,&nbsp;Lema Fikadu Wedajo MSc","doi":"10.1016/j.xagr.2025.100520","DOIUrl":"10.1016/j.xagr.2025.100520","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>One of the issues that contribute to the increase in home births among mothers is the fear of giving birth in an institution. Although delivery services are free in Ethiopia, about half of women chose not to use them because they were afraid of giving birth in a hospital. Home deliveries are the leading cause of morbidity and mortality among mothers and newborns in Ethiopia. One of the major reasons why mothers choose not to give birth in medical facilities is due to fear of an institutional delivery. Nevertheless, no research has been conducted on Ethiopians’ fear of institutional delivery.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to assess the prevalence of fear of institutional delivery and associated factors among postnatal mothers.</div></div><div><h3>STUDY DESIGN</h3><div>Between May 1, 2023, and June 1, 2023, 423 postpartum mothers in Ethiopia’s Honkolo Wabe district participated in a cross-sectional survey. A straightforward random sampling procedure was used to choose study participants. Data were gathered using a standardized questionnaire that was pretested and given by an interviewer in person. To find factors linked to the fear of institutional delivery, bivariate and multivariate analyses were performed. A <em>P</em> value of &lt;.05 with a 95% confidence interval was designated as the level of statistical significance.</div></div><div><h3>RESULTS</h3><div>The overall prevalence of fear of institutional delivery was 43.9% (95% confidence interval, 39.9%–48.2%). Obstetrical violence (adjusted odds ratio, 2.42 [95% confidence interval, 1.20–4.19]), number of children (adjusted odds ratio, 0.39 [95% confidence interval, 0.19–0.82]), poor knowledge on the importance of intuitional delivery (adjusted odds ratio, 2.20 [95% confidence interval, 1.39–3.49]), and a negative attitude toward skilled healthcare services (adjusted odds ratio, 2.13 [95% confidence interval, 1.15–3.94]) were significantly associated factors for fear of childbirth at health facilities.</div></div><div><h3>CONCLUSION</h3><div>Our study found that the prevalence of fear of institutional delivery is high. Therefore, healthcare providers, health extension workers, and other concerned bodies should work on increasing mothers’ knowledge the importance of institutional delivery and their awareness of skilled birth. Similarly, respectful maternity care should be performed in accordance with attracting mothers to health institutions.</div></div>","PeriodicalId":72141,"journal":{"name":"AJOG global reports","volume":"5 3","pages":"Article 100520"},"PeriodicalIF":0.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144306493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AJOG global reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1